Company lists · Data refreshed September 2026
Top 25 Early stage biotech investors based in San Francisco, United States
RevenueBase identified 56 early stage biotech investors headquartered in San Francisco, United States as of September 2026 and tracks 3,887 professional contacts across them, including 386 with verified work emails. New York is the largest hub.
This list covers early stage biotech investors headquartered in San Francisco, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 16, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest early stage biotech investors based in San Francisco, United States
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 3,283 contacts → | ||||
Indirect evidence “Y Combinator is the leading startup accelerator for entrepreneurs.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 2 | 97 contacts → | ||||
Indirect evidence “The Band of Angels is Silicon Valley's oldest seed funding organization.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 3 | 61 contacts → | ||||
Indirect evidence “Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 4 | 45 contacts → | ||||
Indirect evidence “IndieBio is now known as SOSV NY and SOSV SF.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 5 | 44 contacts → | ||||
Indirect evidence “MBC BioLabs believes startups are the greatest force for positive change in the world.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 6 | 29 contacts → | ||||
Strong evidence “Define Ventures is one of the largest funds exclusively focused on early-stage digital health companies with $800 million in assets under management.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 7 | 26 contacts → | ||||
Partial evidence “Yosemite is an oncology-focused venture fund investing in biotech and healthcare innovations to make cancer non-lethal.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 8 | 19 contacts → | ||||
Indirect evidence “At Bee Partners, we passionately believe today’s decades-long supercycle of AI-enabled machines will transform our world via software, hardware, and biology.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 9 | 18 contacts → | ||||
Strong evidence “GreatPoint Ventures is an early-stage venture capital firm founded by entrepreneurs and operators who've built companies cumulatively worth $300 billion.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 10 | 14 contacts → | ||||
Indirect evidence “Headquartered in Silicon Valley, H7 BioCapital is a venture capital firm dedicated to life science investment and Licensing & Strategic Partnership in the pharmaceutical industry.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 11 | 13 contacts → | ||||
Indirect evidence “The UCSF Rosenman Institute is where health innovation becomes action.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 12 | 12 contacts → | ||||
Strong evidence “Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human health Born from our collective…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 13 | 11 contacts → | ||||
Indirect evidence “Greatest venture fund of all time.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 14 | 10 contacts → | ||||
Partial evidence “Biotech, tech-bio, deep tech, hard tech, chem tech… whatever you call this frontier of science and technology, we've been here for over a decade.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 15 | 9 contacts → | ||||
Indirect evidence “Axial partners with great founders and inventors.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 16 | 7 contacts → | ||||
Indirect evidence “We invest in remarkable entrepreneurs working at the intersection of healthcare and technology.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 17 | 7 contacts → | ||||
Partial evidence “Focus Academy enables emerging international biotech companies to enter and thrive in the US market by providing in-depth business, market, and product development programming.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 18 | 7 contacts → | ||||
Strong evidence “BABEL Ventures is leading the charge in early-stage consumer biotech investments.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 19 | 6 contacts → | ||||
Strong evidence “S28 Capital is an early-stage venture fund with $170M under management.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 20 | 6 contacts → | ||||
Indirect evidence “INITIATE funds and co-creates transformational companies - We focus on bold ideas at the intersection of healthcare, life sciences and technology - We are entrepreneurs and…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 21 | 6 contacts → | ||||
Strong evidence “Day One Ventures is an early-stage venture capital firm that backs customer-obsessed companies and spearheads their communications.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 22 | 5 contacts → | ||||
Strong evidence “We make high-conviction, early-stage investments in health tech.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 23 | 5 contacts → | ||||
Strong evidence “Pilatus is a venture capital fund driven by innovation We join forces with early stage enterprises that develop high-impact technologies with global reach.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 24 | 5 contacts → | ||||
Partial evidence “Resolute Ventures is a lead seed and “pre-seed” investor focused on backing and connecting a community of Founders who share an entrepreneurial spirit and energy.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 25 | 5 contacts → | ||||
Strong evidence “Gate 93 is a US-based strategic investment fund targeting successful early stage companies.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: early stage biotech investors. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names early stage biotech investors.
- Partial evidence
- Its own public description names part of early stage biotech investors, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name early stage biotech investors. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 56 early stage biotech investors based in San Francisco, United States
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 386 reachable decision-makers.
Free signup · no credit card
Early stage biotech investors based in San Francisco, United States at a glance
As of Sep 16, 2026Companies by employee count
Email recency for this list is measured across the whole United States list rather than for San Francisco, so it is reported there. Company counts and contact totals on this page are exact for San Francisco, over 56 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among early stage biotech investors, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in San Francisco, United States whose own description of what they do matches “early stage biotech investors”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names early stage biotech investors), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among early stage biotech investors, and records with no verified work email. Companies headquartered outside San Francisco are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 386 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 16, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Early stage biotech investors by metro in the United States
- Early stage biotech investors in New York62
- Early stage biotech investors in San Francisco56
- Early stage biotech investors in Boston40
- Early stage biotech investors in Palo Alto26
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names early stage biotech investors, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many early stage biotech investors are there based in San Francisco, United States?
RevenueBase identified 56 early stage biotech investors headquartered in San Francisco, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Y Combinator, headquartered in San Francisco, tops this list with the largest team on record.
Which city has the most early stage biotech investors?
New York leads with 62 headquartered companies, followed by San Francisco (56) and Boston (40).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 386 verified decision-maker contacts tracked across these 56 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 16, 2026.
Ready to reach these companies? Verified emails and direct dials for all 56 early stage biotech investors based in San Francisco, United States. Start with a free account, no credit card.
Download this list →Related lists
Early stage biotech investors by geography
- Early stage biotech investors based in Boston, United States
- Early stage biotech investors based in New York, United States
- Early stage biotech investors based in Palo Alto, United States
- Early stage biotech investors based in Australia
- Early stage biotech investors based in Canada
- Early stage biotech investors based in France
- Early stage biotech investors based in Germany
- Early stage biotech investors based in India
- Early stage biotech investors based in Israel
- Early stage biotech investors based in the Netherlands
- Early stage biotech investors based in Spain
- Early stage biotech investors based in Switzerland
Browse the directory
Browse: Companies home · Early stage biotech investors in United States · All United States lists · All Early stage biotech investors lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Early stage biotech investors based in Boston, United States
- Early stage biotech investors based in New York, United States
- Early stage biotech investors based in Palo Alto, United States
- Early stage biotech investors based in Australia
- Early stage biotech investors based in Canada
- Early stage biotech investors based in France